Astellas Pharma Ltd

3rd Floor, Future House, The Glanty, Egham, Surrey, TW20 9AH
Telephone: +44 (0)1784 419615
Fax: +44 (0)1784 419583
Medical Information Direct Line: 0800 783 5018
Medical Information e-mail: medinfo@gb.astellas.com

Patient Information Leaflet last updated on the eMC: 14/12/2011
PIL Prograf 0.5mg, 1mg, 5mg Hard Capsules

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 14/12/2011 and displayed until Current
Reasons for adding or updating:
  • Change to date of revision
  • Change to side-effects
Updated on 15/04/2011 and displayed until 14/12/2011
Reasons for adding or updating:
  • Change to date of revision
  • Extra statutory information
  • Change to MA holder contact details
Updated on 16/08/2010 and displayed until 15/04/2011
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 05/08/2010 and displayed until 16/08/2010
Reasons for adding or updating:
  • Change to drug interactions
  • Introduction of new pack/pack size
Updated on 02/06/2009 and displayed until 05/08/2010
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Extra statutory information
Updated on 14/01/2009 and displayed until 02/06/2009
Reasons for adding or updating:
  • Change due to user-testing of patient information
Updated on 02/07/2008 and displayed until 14/01/2009
Reasons for adding or updating:
  • Transfer to upgraded management system
Updated on 17/01/2008 and displayed until 02/07/2008
Reasons for adding or updating:
  • Company name change or merger
Updated on 27/09/2002 and displayed until 17/01/2008
Reasons for adding or updating:
  • Update to PIL
Updated on 01/08/2000 and displayed until 27/09/2002
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
   tacrolimus monohydrate